Companies → UCB Biopharma
Save to list
Remove

UCB Biopharma

Belgium, Bruxelles
Updated Jul 10, 2024 11:34
Description
UCB Biopharma develops, manufactures, markets, and sells innovative human and veterinary biopharmaceutical products focused on the treatment of neurological and immunology disorders. The Company's portfolio includes products marketed under the brand names Briviact, Cimzia, Entocort EC, Keppra, Neupro, Vimpat, and Zyrtec. UCB Biopharma is based in Brussels, Belgium, with operations in more than 40 countries.
Address:

Allée de la Recherche 60 1070

Bruxelles Belgium

Website:
Revenue
$2960.96M
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.